Age-related differences in airway tissue eosinophilia and goblet cell hyperplasia after primary (1°) and secondary (2°) RSV infectiona
1° Infection . | Sham . | uvRSV . | RSV . | uvRSV . | RSV . |
---|---|---|---|---|---|
2° Infection . | . | . | . | RSV . | RSV . |
Tissue eosinophils (MBP-positive cells/mm BM) | |||||
Age at 1° infection | |||||
<1 wk | 3.5 ± 0.8 | 3.3 ± 0.9 | 6.8 ± 1.0b | 2.2 ± 0.8 | 15.6 ± 3.8c |
3 wk | 0.7 ± 0.3 | 0.5 ± 0.3 | 2.1 ± 0.9 | 1.5 ± 0.6 | 0.5 ± 0.1 |
6 wk | 0.6 ± 0.3 | 1.6 ± 0.4 | |||
8 wk | 0.6 ± 0.2 | 1.3 ± 0.4 | |||
Goblet cells (PAS-stained cells/mm BM) | |||||
Age at 1° infection | |||||
<1 wk | 4.5 ± 1.2 | 5.0 ± 0.9 | 21.6 ± 3.0b | 9.8 ± 3.3b | 125.3 ± 15.8c |
3 wk | 1.3 ± 0.2 | 1.8 ± 0.5 | 13.3 ± 2.5b | 12.3 ± 1.7b | 10.0 ± 2.3c |
6 wk | 1.1 ± 0.2 | 11.0 ± 2.4b | |||
8 wk | 1.0 ± 0.3 | 10.4 ± 2.3b |
1° Infection . | Sham . | uvRSV . | RSV . | uvRSV . | RSV . |
---|---|---|---|---|---|
2° Infection . | . | . | . | RSV . | RSV . |
Tissue eosinophils (MBP-positive cells/mm BM) | |||||
Age at 1° infection | |||||
<1 wk | 3.5 ± 0.8 | 3.3 ± 0.9 | 6.8 ± 1.0b | 2.2 ± 0.8 | 15.6 ± 3.8c |
3 wk | 0.7 ± 0.3 | 0.5 ± 0.3 | 2.1 ± 0.9 | 1.5 ± 0.6 | 0.5 ± 0.1 |
6 wk | 0.6 ± 0.3 | 1.6 ± 0.4 | |||
8 wk | 0.6 ± 0.2 | 1.3 ± 0.4 | |||
Goblet cells (PAS-stained cells/mm BM) | |||||
Age at 1° infection | |||||
<1 wk | 4.5 ± 1.2 | 5.0 ± 0.9 | 21.6 ± 3.0b | 9.8 ± 3.3b | 125.3 ± 15.8c |
3 wk | 1.3 ± 0.2 | 1.8 ± 0.5 | 13.3 ± 2.5b | 12.3 ± 1.7b | 10.0 ± 2.3c |
6 wk | 1.1 ± 0.2 | 11.0 ± 2.4b | |||
8 wk | 1.0 ± 0.3 | 10.4 ± 2.3b |
Data are expressed as the mean number of cells (±SEM) detected in central airways. Data are normalized to the length of airway epithelium BM.
Significant difference compared with age-matched, sham-inoculated, control group (p < 0.05).
Significant difference compared with 1° RSV in mice infected at <1 wk of age (p < 0.05).